Proprietary & Confidential—This material is proprietary to My Life Spark P.C. Unauthorized use, reproduction, or distribution is strictly prohibited.

Life Spark Survivorship Institute
GLP-1 series

Module 1 · Cardio-oncology

GLP-1–Based Therapies in Cardio-Oncology

Where GLP-1 biology meets survivorship: cardiometabolic risk reduction across the cancer journey, the muscle guardrail, and a prescribing-to-prevention pathway.

10 slides · 12 minutes

Download the slidesAll modules

What this module covers

  1. 01Cardiometabolic preservation as a survivorship lens
  2. 02Why the GLP-1 interface matters now
  3. 03A multi-organ cardiometabolic signal
  4. 04From glucose control to cardiovascular protection
  5. 05Where to start: survivor populations with visible, modifiable risk
  6. 06Safety: the guardrail is muscle
  7. 07Periprocedural planning
  8. 08From prescribing to prevention
  9. 09Precision survivorship as the destination

Key takeaways

Obesity in survivors carries cardiovascular biology, not just weight.

Lean mass is the safety guardrail for every escalation decision.

Periprocedural care needs a shared, documented plan.

Continue the series

Module 2

GLP-1 Receptor Agonist Therapy: The Complete Briefing

Module 3

Obesity, Cardiometabolic Health & GLP-1 Therapies

Module 4

Managing Adverse Effects & Safety Considerations

Educational information only. It does not replace advice from your oncology or primary care team, and no treatment decision should be made from this module alone.